RadNet

RDNT

Market cap $5.63B

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, Dr. Gregory Sorensen, Executive Vice President and Chief Strategy Officer and Kees Wesdorp, President & CEO of RadNet Digital Health will be presenting at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 10:30 a.m. PST.

LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today that it has acquired Radiology Regional, a division of LucidHealth serving Southwest Florida. The expansion brings RadNet's proven operational efficiencies and leading imaging technologies to 13 locations across Naples, Cape Coral, Fort Myers, Port Charlotte and Sarasota.

RadNet, Inc. (NASDAQ: RDNT) stock is trading lower on Tuesday. Hunterbrook Capital released a short report on Tuesday on the company, stating that the smaller companies are slapping "AI" on their pitch decks and watching their valuations soar.

Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates, 1 risk stratification tools, and viewing and reporting workflow acceleration CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced today the launch of the DeepHealth Breast Suite, 2 a first-of-its-kind end-to-end suite of modular, interoperable AI-powered applications that address real-world clinical needs across the breast cancer screening and detection pathways. Breast Suite builds on organic innovation and integrated technologies from iCAD to deliver a comprehensive new suite of solutions.

CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today unveils an expanded portfolio at RSNA 2025, introducing next-generation imaging informatics and clinical AI solutions. The company is announcing new offerings and major enhancements across its portfolio, spanning disease detection, assessment and monitoring, remote scanning, image management and interpretation, center operations and AI orchestration—all designed to transform the imaging experience and advance population health.

Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations

GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities

Acquisition supplements CIMAR's cloud-native infrastructure with DeepHealth's AI-powered informatics to deliver connected, efficient and accessible care

RadNet, Inc. ( RDNT ) Q3 2025 Earnings Call November 10, 2025 10:30 AM EST Company Participants Mark Stolper - Executive VP & CFO Howard Berger - Chairman, President & CEO Conference Call Participants David MacDonald - Truist Securities, Inc., Research Division Brian Tanquilut - Jefferies LLC, Research Division John Ransom - Raymond James & Associates, Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to the RadNet Inc. Third Quarter 2025 Financial Results Conference Call.

While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.